Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Endocrine. 2017 Apr 12;58(3):503–512. doi: 10.1007/s12020-017-1295-4

Table 1.

Baseline clinical and biochemical characteristics of patients with APAs and concurrent SCH

Case n° Age /sex SBP/DBP
(mmHg)
No. of
drugs
before AVS
Serum K
mmol/L)
Plasma
aldosterone
(pmol/L)
PRA (ng/
ml per h)
DRC
(mU/L)
ARR ACTH
(pmol/L)
Urinary
Cortisol
(nmol/24 h)
Serum
cortisol
(nmol/L)
Serum cortisol
by 1 mg DST
(nmol/L)
CT scan Laterality at
AVS
1 51/F 149/90 2 2.5 1387.2 9.4 147.5 1.32 456 278.3 187.6 Right nodule Right APA Right SCH
2 63/F 144/98 2 2.8 1409.1 7.9 178.3 0.44 339 303.1 190.1 Right nodule Right APA Right SCH
3 64/M 187/106 4 2.8 1687.9 10.9 154.8 0.88 554 942.5 96.4 Left nodule Left APA Left SCH
4 43/F 170/102 3 1.9 1054.2 0.2 5271 2.86 937 355.5 104.7 Left nodule NA
5 72/M 180/100 3 2.9 1095.7 0.1 10957 1.54 885 509.8 77.1 Right nodule NA

Serum K refers to the lowest measured concentration

SBP systolic blood pressure, DBP diastolic blood pressure, PRA plasma renin activity, DRC direct renin concentration, ARR aldosterone-to-renin ratio, DST dexamethasone suppression test, CT computed tomography, AVS adrenal venous sampling, SCH subclinical cortisol hypersecretion, NA not available